Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

464 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predicting the Pathologic Complete Response After Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer.
Bandini M, Ross JS, Raggi D, Gallina A, Colecchia M, Lucianò R, Giannatempo P, Farè E, Pederzoli F, Bianchi M, Colombo R, Gandaglia G, Fossati N, Marandino L, Capitanio U, Deho' F, Ali SM, Madison R, Chung JH, Salonia A, Briganti A, Montorsi F, Necchi A. Bandini M, et al. Among authors: necchi a. J Natl Cancer Inst. 2021 Jan 4;113(1):48-53. doi: 10.1093/jnci/djaa076. J Natl Cancer Inst. 2021. PMID: 32516377 Free PMC article. Clinical Trial.
Understanding the somatic-type malignant differentiation in male germ-cell cancer: a work in progress. Response to the article by Spiess et al., Malignant transformation of testicular teratoma: a chemoresistant phenotype. Urol Oncol 2008;26:595-9.
Necchi A, Nicolai N, Colecchia M, Salvioni R. Necchi A, et al. Urol Oncol. 2009 Mar-Apr;27(2):218; author reply 218-9. doi: 10.1016/j.urolonc.2008.12.009. Urol Oncol. 2009. PMID: 19285238 No abstract available.
Penile cancer.
Salvioni R, Necchi A, Piva L, Colecchia M, Nicolai N. Salvioni R, et al. Among authors: necchi a. Urol Oncol. 2009 Nov-Dec;27(6):677-85. doi: 10.1016/j.urolonc.2009.07.017. Urol Oncol. 2009. PMID: 19879479
Concordance and prediction ability of original and reviewed vascular invasion and other prognostic parameters of clinical stage I nonseminomatous germ cell testicular tumors after retroperitoneal lymph node dissection.
Nicolai N, Colecchia M, Biasoni D, Catanzaro M, Stagni S, Torelli T, Necchi A, Piva L, Milani A, Salvioni R. Nicolai N, et al. Among authors: necchi a. J Urol. 2011 Oct;186(4):1298-302. doi: 10.1016/j.juro.2011.05.070. Epub 2011 Aug 17. J Urol. 2011. PMID: 21849196
[The treatment of early-stage germ cell tumors of the testis (GCTT)].
Salvioni R, Nicolai N, Necchi A, Torelli T, Piva L, Stagni S, Catanzaro MA, Biasoni D, Milani A, Colecchia M, Spreafico C, Morosi C, Marchianò A, Crippa F. Salvioni R, et al. Among authors: necchi a. Urologia. 2012 Apr-Jun;79(2):81-8. doi: 10.5301/RU.2012.9047. Urologia. 2012. PMID: 22344569 Review. Italian.
Pazopanib in advanced and platinum-resistant urothelial cancer: an open-label, single group, phase 2 trial.
Necchi A, Mariani L, Zaffaroni N, Schwartz LH, Giannatempo P, Crippa F, Morosi C, Lanocita R, Sava T, Ortega C, Messina C, Sacco C, Pennati M, Daidone MG, Nicolai N, De Braud F, Gianni AM, Salvioni R. Necchi A, et al. Lancet Oncol. 2012 Aug;13(8):810-6. doi: 10.1016/S1470-2045(12)70294-2. Epub 2012 Jul 20. Lancet Oncol. 2012. PMID: 22819172 Clinical Trial.
New directions for biologic targets in urothelial carcinoma--letter.
Necchi A, Mariani L, Zaffaroni N, Giannatempo P, Salvioni R. Necchi A, et al. Mol Cancer Ther. 2012 Oct;11(10):2306; author reply 2307. doi: 10.1158/1535-7163.MCT-12-0515. Epub 2012 Oct 2. Mol Cancer Ther. 2012. PMID: 23033488 No abstract available.
464 results